Cystic fibrosis newborn screening

Area of Science:

• Genetics
• Pediatrics
• Medical Diagnostics

Background:

• Cystic fibrosis (CF) is a severe autosomal recessive genetic disorder affecting approximately 1 in 3500 newborns in the US.
• Advances in newborn screening have improved early detection of CF.
• Diagnosing CF in newborns can be complex, even for specialists.

Purpose of the Study:

• To discuss the pathogenesis of cystic fibrosis.
• To highlight the importance and process of newborn screening for CF.
• To provide resources for healthcare providers in Arkansas regarding CF diagnosis and treatment.

Main Methods:

• Review of cystic fibrosis pathogenesis, focusing on the CFTR gene mutation on chromosome 7.
• Explanation of the rationale and algorithm for newborn screening for CF.
• Provision of contact information for CF diagnostic and treatment resources in Arkansas.

Main Results:

• Cystic fibrosis results from mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
• CFTR protein, responsible for chloride ion transport, is crucial for cellular function.
• Newborn screening algorithms are essential for timely CF diagnosis.

Conclusions:

• Early detection of cystic fibrosis through newborn screening is vital for improved patient outcomes.
• Understanding CF pathogenesis and screening protocols is critical for healthcare providers.
• Access to specialized resources is necessary for managing CF in newborns.